73.03
price up icon0.40%   0.29
after-market After Hours: 73.03
loading
Bio Techne Corp stock is traded at $73.03, with a volume of 308.52K. It is up +0.40% in the last 24 hours and up +2.46% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$72.74
Open:
$72.63
24h Volume:
308.52K
Relative Volume:
0.36
Market Cap:
$11.60B
Revenue:
$1.17B
Net Income/Loss:
$150.71M
P/E Ratio:
48.05
EPS:
1.52
Net Cash Flow:
$245.03M
1W Performance:
-2.98%
1M Performance:
+2.46%
6M Performance:
-1.96%
1Y Performance:
-5.79%
1-Day Range:
Value
$72.49
$73.38
1-Week Range:
Value
$69.48
$75.94
52-Week Range:
Value
$61.16
$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name
Name
Bio Techne Corp
Name
Phone
(612) 379-8854
Name
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Employee
3,100
Name
Twitter
@biotechne
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
TECH's Discussions on Twitter

Compare TECH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECH
Bio Techne Corp
73.03 11.60B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.18 105.12B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
714.47 78.51B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
629.99 37.67B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.25 31.37B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.13 27.36B 3.30B -501.07M 1.03B -2.1146

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date Action Analyst Rating Change
May-22-24 Downgrade Citigroup Buy → Neutral
Feb-08-24 Initiated Scotiabank Sector Outperform
Feb-02-24 Downgrade Stifel Buy → Hold
Dec-07-23 Initiated UBS Buy
Aug-28-23 Initiated William Blair Outperform
Jan-10-23 Upgrade Wells Fargo Underweight → Equal Weight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-12-22 Upgrade Citigroup Neutral → Buy
Dec-07-22 Initiated RBC Capital Mkts Sector Perform
Aug-25-22 Initiated Credit Suisse Outperform
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Sep-15-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-08-21 Upgrade Stephens Equal-Weight → Overweight
Feb-23-21 Upgrade Stifel Hold → Buy
Jan-25-21 Reiterated The Benchmark Company Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Jul-15-20 Downgrade Stephens Overweight → Equal-Weight
May-27-20 Downgrade Stifel Buy → Hold
May-14-20 Initiated The Benchmark Company Buy
Jan-08-20 Resumed Stephens Overweight
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Nov-15-19 Initiated Stifel Buy
Jul-02-19 Upgrade Janney Neutral → Buy
Jan-14-19 Upgrade Stephens Equal-Weight → Overweight
Oct-31-18 Downgrade Craig Hallum Buy → Hold
Oct-17-18 Initiated Goldman Neutral
Jun-15-18 Initiated Argus Buy
Jul-13-17 Initiated Wells Fargo Market Perform
Feb-09-17 Initiated Citigroup Buy
Jan-18-17 Initiated Deutsche Bank Buy
Nov-10-16 Resumed Leerink Partners Outperform
Jan-21-15 Reiterated Robert W. Baird Outperform
Sep-20-13 Upgrade Robert W. Baird Neutral → Outperform
View All

Bio Techne Corp Stock (TECH) Latest News

pulisher
Dec 23, 2024

How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks? - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain? - Yahoo Finance

Dec 23, 2024
pulisher
Dec 20, 2024

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Financial Times

Dec 20, 2024
pulisher
Dec 19, 2024

Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

Bio-Techne partners with Waters for biotherapeutic tech - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - Yahoo Finance

Dec 19, 2024
pulisher
Dec 18, 2024

ScaleReady awards a G-Rex® Grant to Moonlight Bio - Yahoo Finance

Dec 18, 2024
pulisher
Dec 16, 2024

Lord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Bio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in November - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion Bank - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Oddo BHF Asset Management Sas Invests $1.19 Million in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Barclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? - MSN

Dec 13, 2024
pulisher
Dec 13, 2024

National Bank of Canada FI Purchases 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 13, 2024
pulisher
Dec 12, 2024

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - Quantisnow

Dec 12, 2024
pulisher
Dec 11, 2024

S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's

Dec 11, 2024
pulisher
Dec 10, 2024

West Sac-based GeminiBio acquires a large serum producer's brands, customers - The Business Journals

Dec 10, 2024
pulisher
Dec 10, 2024

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - Yahoo Finance

Dec 10, 2024
pulisher
Dec 10, 2024

Wellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

State Street Corp Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 09, 2024
pulisher
Dec 08, 2024

Tenere Capital LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Worldquant Millennium Advisors LLC Buys 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Polar Asset Management Partners Inc. Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Janus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum? - Yahoo Finance

Dec 04, 2024
pulisher
Dec 04, 2024

PEAK6 Investments LLC Invests $698,000 in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance

Dec 03, 2024
pulisher
Dec 03, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Why Bio-Techne Corp (TECH) Is Set to Outperform the Market: Insi - GuruFocus.com

Dec 02, 2024
pulisher
Dec 02, 2024

Bamco Inc. NY Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Should You Continue to Retain Bio-Techne Stock in Your Portfolio? - Yahoo Finance

Dec 02, 2024
pulisher
Dec 02, 2024

BNP Paribas Financial Markets Sells 52,235 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

The Manufacturers Life Insurance Company Has $15.93 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

American Capital Management Inc. Has $89.07 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Fred Alger Management LLC Has $52.07 Million Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 30, 2024
pulisher
Nov 30, 2024

Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $81.78 - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

TECH (Bio-Techne) 3-Year Revenue Growth Rate : 7.80% (As of Sep. 2024) - GuruFocus.com

Nov 29, 2024
pulisher
Nov 29, 2024

Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Nov 29, 2024
pulisher
Nov 29, 2024

Dai ichi Life Insurance Company Ltd Has $423,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance

Nov 29, 2024
pulisher
Nov 27, 2024

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE - Quantisnow

Nov 27, 2024
pulisher
Nov 27, 2024

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE – Company Announcement - Financial Times

Nov 27, 2024
pulisher
Nov 26, 2024

Charles Schwab Investment Management Inc. Has $113.02 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Bio-Techne Co. (NASDAQ:TECH) Position Raised by Cerity Partners LLC - MarketBeat

Nov 26, 2024
pulisher
Nov 25, 2024

Bio-Techne (TECH) Shares Cross Above 200 DMA - Nasdaq

Nov 25, 2024
pulisher
Nov 23, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Eagle Asset Management Inc. - MarketBeat

Nov 23, 2024
pulisher
Nov 23, 2024

Massachusetts Financial Services Co. MA Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 23, 2024
pulisher
Nov 23, 2024

Mutual of America Capital Management LLC Purchases 8,852 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

Bio-Techne (MEX:TECH) Dividend Payout Ratio : 0.19 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024
pulisher
Nov 21, 2024

Bio-Techne (MEX:TECH) Debt-to-Equity : 0.19 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart

Nov 21, 2024

Bio Techne Corp Stock (TECH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$69.91
price up icon 0.10%
$19.00
price up icon 1.77%
$40.27
price up icon 1.72%
$360.87
price down icon 0.76%
$181.62
price up icon 2.21%
$114.13
price up icon 0.55%
Cap:     |  Volume (24h):